|
|
||||||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Mon., Apr. 28, 10:45 AM
|
|||||||||||||||||||||||||||||||||||||||||||
Stock Splits
| This Slide: #2 of 25 |
Slide #2. X4 Pharmaceuticals (NASDAQ:XFOR) — 1 for 30 Reverse Split
Announced:
4/24/2025
Stock Split:
1 for 30
Record Date:
4/25/2025
Pay Date:
4/28/2025
XFOR Optionable?:
Yes
X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on discovering and developing novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. Its lead clinical candidate is mavorixafor, a small-molecule selective antagonist of chemokine receptor CXCR4, that is being developed as an oral, once-daily therapy. It has developed a pipeline of small-molecule, oral antagonists of the chemokine receptor C-X-C receptor type 4 (CXCR4).
XFOR SEC Filing Email Alerts Service
XFOR Detailed Information Page & Split History »
|
|||||||||||||||
Open the XFOR Page at The Online Investor (in a new window) »
 Free XFOR Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 77th percentile
(ranked higher than approx. 77% of all stocks covered)
Analysts' Target Price: XFOR Stock Forecast Based on Zacks ABR data; powered by Xignite |
Stock Splits | www.TheOnlineInvestor.com | Copyright © 1998 - 2025, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.